Canola-Mediterranean Diet Study in T2DM
Canola Enriched Mediterranean Type Weight Loss Diet in Type 2 Diabetes
2 other identifiers
interventional
164
1 country
3
Brief Summary
The purpose of the study is to assess whether a Mediterranean-type weight-loss diet, enriched with canola oil, high in plant protein, and low in carbohydrates will produce blood sugar control, reduce coronary heart disease (CHD) risk factors and maximize weight loss, better than conventional higher carbohydrate diets in overweight diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Started Oct 2014
Typical duration for not_applicable type-2-diabetes
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2014
CompletedFirst Posted
Study publicly available on registry
September 19, 2014
CompletedStudy Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2017
CompletedSeptember 18, 2018
September 1, 2018
2.2 years
September 5, 2014
September 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in HbA1c
The baseline HbA1c will be the average HbA1c of weeks -2 and week 0. The end HbA1c will be the average HbA1c of weeks 8, 10 and 12. Change will be the difference between the end and baseline values
Measured at weeks -2, 0, and then at weeks 8, 10 and 12
Secondary Outcomes (10)
Change in body weight
baseline (week 0) and end (week 12)
blood glucose
At weeks 0, 2, 4, 8, 10 and 12
Serum lipids: total cholesterol, LDL-chol, HDL-chol and Triglycerides
At weeks 0, 4, 8, 10 and 12
Blood pressure
At weeks 0, 4, 8, 10 and 12
24-hour Ambulatory blood pressure profile
At weeks -1 and 12
- +5 more secondary outcomes
Other Outcomes (11)
Satiety
at weeks 0, 2, 4, 8, 10 and 12
Taste (palatability) of the study diets, breads and other supplements given
At weeks 2, 4, 8, 10 and 12
The Medical Outcomes Study 36-Item Short Form Questionnaire (SF-36)
At weeks 0 and 12
- +8 more other outcomes
Study Arms (2)
A canola oil enriched mediterranean diet
EXPERIMENTALParticipants will be advised to consume, a low-carbohydrate diet (26-32% of calories), high in vegetable protein (28-32%) and fat (41-45%) with canola as the major component (10%). Carbohydrate sources will feature viscous fiber-containing foods (including psyllium cereal, oats and barley) and low-starch vegetables (emphasizing okra and eggplant) for the relatively limited amount of carbohydrate.
A high wheat fiber diet
ACTIVE COMPARATORParticipant will be advised to consume a high carbohydrate diet (58% carbohydrate, 16% protein and 25% fat) emphasizing whole wheat/whole grain cereals and increased high fiber alternatives, with fruits and vegetables.
Interventions
The diet will be provided at 60% of calories estimated for stable body weight to encourage weight loss. A high protein canola oil-enriched test bread will be provided as a supplement.
The diet will be provided at 60% of calories estimated for stable body weight to encourage weight loss. A whole wheat control bread will be provided as a supplement to participants
Eligibility Criteria
You may qualify if:
- Men and women with type 2 diabetes diagnosed for more than 6 months
- BMI \>27 (non-Asians); BMI \>25 (Asians)
- HbA1c between 6.5% and 8.5% at screening, and at the preparation visit before starting diet
- on a stable prescribed dose of oral diabetes medication for at least 2 months
- on a stable dose of lipid medication for at least 2 weeks, if prescribed
- on a stable dose of blood pressure medication for at least 1 week, if prescribed
- have a family physician
- can keep written food records, with the use of a digital scale
You may not qualify if:
- Individuals with the following characteristics/conditions will be excluded
- on insulin
- on steroids
- on warfarin (Coumadin)
- GI disease (gastroparesis, celiac, colitis, Crohn's disease, Inflammatory Bowel Syndrome)
- history of cancer, except non-melanoma skin cancer (basal cell, squamous cell)
- major cardiovascular event (stroke, myocardial infarction) in past 6 months
- major surgery in past 6 months
- major debilitating disorder
- liver disease (AST or ALT\> 3x the upper limit of normal) except non-alcoholic fatty liver (NAFL) disease or non-alcoholic steatohepatitis (NASH).
- hepatitis B or C
- renal failure (creatinine \> 150 mmol/L)
- serum triglycerides \>4.5mmol/L
- acute or chronic infections (bacterial or viral)
- chronic inflammatory diseases (e.g. lupus, ulcerative colitis)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- University of Torontocollaborator
- Laval Universitycollaborator
- University of Manitobacollaborator
- Canola Council of Canadacollaborator
Study Sites (3)
Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Winnipeg, Manitoba, R3T 6C5, Canada
Risk Factor Modification Centre, St. Michael's Hospital
Toronto, Ontario, M5C 2T2, Canada
Institute of Nutraceuticals and Functional Foods, Laval University
Québec, Quebec, G1V 4G2, Canada
Related Publications (11)
Alhassan S, Kim S, Bersamin A, King AC, Gardner CD. Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study. Int J Obes (Lond). 2008 Jun;32(6):985-91. doi: 10.1038/ijo.2008.8. Epub 2008 Feb 12.
PMID: 18268511BACKGROUNDAnderson JW, Randles KM, Kendall CW, Jenkins DJ. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr. 2004 Feb;23(1):5-17. doi: 10.1080/07315724.2004.10719338.
PMID: 14963049BACKGROUNDShai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229-41. doi: 10.1056/NEJMoa0708681.
PMID: 18635428BACKGROUNDJenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, Faulkner DA, Vidgen E, Greaves KA, Paul G, Singer W. The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med. 2009 Jun 8;169(11):1046-54. doi: 10.1001/archinternmed.2009.115.
PMID: 19506174BACKGROUNDGuariguata L, Whiting D, Weil C, Unwin N. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res Clin Pract. 2011 Dec;94(3):322-32. doi: 10.1016/j.diabres.2011.10.040. Epub 2011 Nov 17.
PMID: 22100977BACKGROUNDKris-Etherton P, Eckel RH, Howard BV, St Jeor S, Bazzarre TL; Nutrition Committee Population Science Committee and Clinical Science Committee of the American Heart Association. AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation. 2001 Apr 3;103(13):1823-5. doi: 10.1161/01.cir.103.13.1823. No abstract available.
PMID: 11282918BACKGROUNDSacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009 Feb 26;360(9):859-73. doi: 10.1056/NEJMoa0804748.
PMID: 19246357BACKGROUNDFriedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499-502. No abstract available.
PMID: 4337382BACKGROUNDJenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, Faulkner DA, Vidgen E, Paul G, Mukherjea R, Krul ES, Singer W. Effect of a 6-month vegan low-carbohydrate ('Eco-Atkins') diet on cardiovascular risk factors and body weight in hyperlipidaemic adults: a randomised controlled trial. BMJ Open. 2014 Feb 5;4(2):e003505. doi: 10.1136/bmjopen-2013-003505.
PMID: 24500611BACKGROUNDGremaud G, Piguet C, Baumgartner M, Pouteau E, Decarli B, Berger A, Fay LB. Simultaneous assessment of cholesterol absorption and synthesis in humans using on-line gas chromatography/ combustion and gas chromatography/pyrolysis/isotope-ratio mass spectrometry. Rapid Commun Mass Spectrom. 2001;15(14):1207-13. doi: 10.1002/rcm.365.
PMID: 11445904BACKGROUNDJenkins DJ, Jones PJ, Abdullah MM, Lamarche B, Faulkner D, Patel D, Sahye-Pudaruth S, Paquette M, Bashyam B, Pichika SC, Kavanagh ME, Patel P, Liang F, Brown R, Zhao T, Phan M, Mathiyalagan G, Tandon S, Vuksan V, Jovanovski E, Sievenpiper JL, Kendall CW, Leiter LA, Josse RG. Low-carbohydrate vegan diets in diabetes for weight loss and sustainability: a randomized controlled trial. Am J Clin Nutr. 2022 Nov;116(5):1240-1250. doi: 10.1093/ajcn/nqac203. Epub 2023 Feb 10.
PMID: 36156115DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David J Jenkins, MD
St. Michael's Hospital / University of Toronto
- STUDY DIRECTOR
Cyril Kendall, PhD
University of Toronto
- STUDY DIRECTOR
Vladimir Vuksan, PhD
Unity Health Toronto
- STUDY DIRECTOR
Peter Jones, PhD
University of Manitoba
- STUDY DIRECTOR
Benoit Lamarche, PhD
Laval University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2014
First Posted
September 19, 2014
Study Start
October 1, 2014
Primary Completion
December 14, 2016
Study Completion
March 13, 2017
Last Updated
September 18, 2018
Record last verified: 2018-09